• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Helix Therapeutics

edit

Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis.

Recent Milestones

edit

• 
  Helix Therapeutics received $2.5M in Venture Round funding. (11/23/10)
  Posted 11/23/10 at 6:01pm via finsmes.com
• 
  Helix Therapeutics received $600k in Venture Round funding. (1/11/10)
  Posted 1/12/10 at 5:59am via masshightech.com
• 
  Helix Therapeutics added Joseph J. Catino as President & CEO.
  Posted 1/12/10 at 5:59am
• 
  Helix Therapeutics added Peter M. Glazer as Founder.
  Posted 1/12/10 at 5:59am
• 
  Helix Therapeutics added Ranjit S. Bindra as Founder.
  Posted 1/16/10 at 6:11pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/12/10

Sources

1. Helix Therapeutics lands $600K funding (masshightech.com) [edit]
2. Helix Therapeutics Raises $2.5M (finsmes.com) [edit]